216 related articles for article (PubMed ID: 21779388)
1. A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
Zhang J; Ma Z; Dong N; Liu F; Su J; Zhao Y; Shen F; Wang A; Ruan C
PLoS One; 2011; 6(7):e22157. PubMed ID: 21779388
[TBL] [Abstract][Full Text] [Related]
2. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
Rauch A; Legendre P; Christophe OD; Goudemand J; van Belle E; Vincentelli A; Denis CV; Susen S; Lenting PJ
Thromb Haemost; 2014 Nov; 112(5):1014-23. PubMed ID: 25030452
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
Chen J; Ling M; Fu X; López JA; Chung DW
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
[TBL] [Abstract][Full Text] [Related]
4. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
[TBL] [Abstract][Full Text] [Related]
5. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
Nishio K; Anderson PJ; Zheng XL; Sadler JE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
[TBL] [Abstract][Full Text] [Related]
6. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis.
Baldauf C; Schneppenheim R; Stacklies W; Obser T; Pieconka A; Schneppenheim S; Budde U; Zhou J; Gräter F
J Thromb Haemost; 2009 Dec; 7(12):2096-105. PubMed ID: 19817991
[TBL] [Abstract][Full Text] [Related]
7. A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13.
Zhang L; Su J; Shen F; Ma Z; Zhao Y; Xia L; Ruan C
J Hematol Oncol; 2017 Feb; 10(1):42. PubMed ID: 28166803
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.
Wang A; Liu F; Dong N; Ma Z; Zhang J; Su J; Zhao Y; Ruan C
Thromb Res; 2010 Oct; 126(4):e260-5. PubMed ID: 20705333
[TBL] [Abstract][Full Text] [Related]
9. [ADAMTS13-Mediated Proteolytic Cleavage of Unusually Large von Willebrand Factor Polymers on Endothelial Cells in the Absence of Fluid Shear Stress].
Zhao SC; Li H; Wang M; Zhao YH; Li XJ; Jin SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):532-540. PubMed ID: 38660863
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress.
Skipwith CG; Cao W; Zheng XL
J Biol Chem; 2010 Sep; 285(37):28596-603. PubMed ID: 20605782
[TBL] [Abstract][Full Text] [Related]
11. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
[TBL] [Abstract][Full Text] [Related]
12. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
Hassenpflug WA; Budde U; Obser T; Angerhaus D; Drewke E; Schneppenheim S; Schneppenheim R
Blood; 2006 Mar; 107(6):2339-45. PubMed ID: 16322474
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
[TBL] [Abstract][Full Text] [Related]
14. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
[TBL] [Abstract][Full Text] [Related]
15. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
Xiang Y; de Groot R; Crawley JT; Lane DA
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
[TBL] [Abstract][Full Text] [Related]
17. An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.
Pos W; Crawley JT; Fijnheer R; Voorberg J; Lane DA; Luken BM
Blood; 2010 Feb; 115(8):1640-9. PubMed ID: 20032502
[TBL] [Abstract][Full Text] [Related]
18. Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.
Hayakawa M; Kato S; Matsui T; Sakai K; Fujimura Y; Matsumoto M
J Thromb Haemost; 2019 Jun; 17(6):975-983. PubMed ID: 30929293
[TBL] [Abstract][Full Text] [Related]
19. Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro.
Brophy TM; Ward SE; McGimsey TR; Schneppenheim S; Drakeford C; O'Sullivan JM; Chion A; Budde U; O'Donnell JS
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):845-855. PubMed ID: 28279966
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein B100/Low-Density Lipoprotein Regulates Proteolysis and Functions of von Willebrand Factor under Arterial Shear.
Cao W; Abdelgawwad MS; Li J; Zheng XL
Thromb Haemost; 2019 Dec; 119(12):1933-1946. PubMed ID: 31493779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]